Pharma
Times
Virupaksha Organics Ltd. has established itself as a trusted name in the global pharmaceutical market, specializing in the production of Fluconazole, a critical antifungal medication used to treat a wide range of fungal infections. With state-of-the-art manufacturing facilities located in Telangana, India, the company adheres to the highest standards of quality, safety, and regulatory compliance to produce high-purity Fluconazole for both domestic and international markets.
Fluconazole is widely prescribed to treat conditions like candidiasis and cryptococcal meningitis, and Virupaksha Organics’ commitment to producing this essential API ensures a reliable supply to healthcare providers worldwide. The company’s facilities are WHO-GMP, ISO 9001, and ISO 14001 certified, reflecting its dedication to maintaining excellence in manufacturing while also being environmentally conscious.
By leveraging cutting-edge technology and a robust research and development process, Virupaksha continues to meet the growing global demand for Fluconazole, ensuring that patients receive effective and affordable treatment. As part of its mission to be a research-driven pharmaceutical company, Virupaksha Organics remains a trusted partner for pharmaceutical companies around the globe, delivering high-quality APIs with a focus on customer satisfaction and sustainability.
With its expanding global footprint, Virupaksha Organics Ltd. is poised to remain at the forefront of the pharmaceutical industry, particularly in the production of vital medications like Fluconazole, helping to combat fungal infections and improve health outcomes worldwide.
Latest Update
- Mexico, Served With A SOCIAL Twist
- TN Budget Eyes Cross-Border Metro Rail Link with Karnataka's Bommasandra
- Australia Not Planning Tour Match Before India Test Series, Says Coach McDonald
- Karnataka To Introduce Dedicated Menopause Health Policy for Women
- Samantha Shares Heartfelt Birthday Wish for Husband Raj Nidimoru
- CM DK Shivakumar Asked To Resign, Will Decide After Discussion: Karnataka LC Chairman
- US: Chipotle Pulls Jalapeños Over Salmonella Outbreak Probe
- Jayam Ravi in Talks to Play Lord Venkateswara Amid Divorce Battle?
- Mahesh Babu Makes the Most of Family Holiday
- Google Shares First Pixel 11 Pro Fold Teaser, Launch Set For August 12
- Suspected Heatstroke Kills Three Lions At Japan Zoo
- Human Remains Found in Suitcase on Tamil Nadu Express at Agra Cantt Station
- Kerala CM Satheesan To Hold Talks With TN CM Vijay Over Mullaperiyar
- SC Asks States to Revisit Raising Judicial Officers' Retirement Age
- DFGC, UNICEF India Renew Partnership to Boost Early Childhood Disability Care
- From Reel to Real: Tarun Tejpal’s courtroom battle echoes 1993 blockbuster ‘Damini’
- Canadian Open: Iga Swiatek cruises into fourth round; Alexandra Eala advances in Toronto
- PM Modi urges youth to celebrate National Handloom Day like Friendship Day
- Permission restored for Rahul Gandhi’s ‘Chhatron Ki Goonj’ event in Prayagraj
- Indian coffee exports reach 140 countries in FY2025–26
- Microsoft opens Hyderabad cloud region to boost India’s AI, cloud infra
- Medico declared brain-dead after alleged drunk driving incident at Andhra mall; two arrested
- Jharkhand exam protest: Protesters form panel for govt talks on Day 13
- Indian envoy Sumit Seth meets Panama President Jose Raul Mulino, discusses strengthening bilateral ties
- Nirmala Sitharaman rebuts Jairam Ramesh over UPI Bill, says MDR will not apply to customers
- Gen Z protests are not anti-national, grievances are genuine: RSS chief Mohan Bhagwat
- Gen Z more honest than previous generations, says RSS chief Mohan Bhagwat
- LGBTQIA plus community is part of society, but marriage should not be altered now: RSS chief Mohan Bhagwat
- India U20 men beat Singapore to continue AFC Asian Cup preparations
- Centre opposes creamy layer in SC/ST reservations, tells Supreme Court policy needs empirical study